A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma
- PMID: 33231508
- DOI: 10.1177/0194599820973241
A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma
Abstract
Objectives: To comprehensively investigate nasopharyngeal carcinoma (NPC) treatment, overall survival (OS), and the influence of clinical/sociodemographic factors on outcome.
Study design: Retrospective database study.
Setting: National Cancer Database.
Methods: The 2004-2015 National Cancer Database was queried for all patients with NPC receiving definitive treatment. Log-rank tests and Cox proportional hazards models were used for statistical analyses.
Results: A total of 8260 patients with NPC were included (71.4% male; 42.5% with keratinizing histology; mean ± SD age, 52.1 ± 15.1 years), with a 5-year OS of 63.4%. Multivariate predictors of mortality included age ≥65 years (hazard ratio [HR], 1.81; P < .001), Charlson/Deyo score ≥1 (HR, 1.27; P = .001), American Joint Committee on Cancer clinical stage III to IV (HR, 1.85; P < .001), and government insurance or no insurance (HR, 1.53; P < .001). Predictors of survival included female sex (HR, 0.82; P = .002), Asian/Pacific Islander race (HR, 0.74; P < .001), nonkeratinizing/undifferentiated histology (HR, 0.79; P = .004), and receiving treatment at academic centers (HR, 0.87; P = .02). Chemoradiotherapy (CRT) demonstrated improved OS as compared with radiotherapy (RT) only for stage II (P = .006) and stage III (P = .005) and with RT or chemotherapy only in stage IVA NPC (P < .001). When compared with CRT alone, surgery plus CRT provided OS benefits in keratinizing (P = .013) or stage IVA (P = .030) NPC. When compared with RT, CRT provided OS benefits in keratinizing (P = .005) but not nonkeratinizing (P = .240) or undifferentiated (P = .390) NPC. Substandard radiation dosing of <60 Gy and <30 fractions were associated with inferior OS (both P < .001).
Conclusions: NPC survival is dependent on a variety of clinical/sociodemographic factors. Stage-specific treatments with optimal OS include CRT or RT for stages I to II and CRT for stage III to IV. The large representation of nonendemic histology is valuable, as these cases are not well characterized.
Keywords: NCDB; NPC; chemoradiotherapy; nasopharyngeal carcinoma; overall survival; radiation oncology.
Similar articles
-
Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.Head Neck. 2019 Dec;41(12):4076-4087. doi: 10.1002/hed.25955. Epub 2019 Sep 14. Head Neck. 2019. PMID: 31520512
-
Evaluating the Efficacy of Different Treatment Intensities in Nasopharyngeal Carcinoma Patients: A Nationwide Cancer Registry-Based Study.Ann Surg Oncol. 2024 Dec;31(13):9125-9133. doi: 10.1245/s10434-024-16145-4. Epub 2024 Sep 6. Ann Surg Oncol. 2024. PMID: 39240395
-
Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.Am J Otolaryngol. 2022 Jan-Feb;43(1):103193. doi: 10.1016/j.amjoto.2021.103193. Epub 2021 Sep 3. Am J Otolaryngol. 2022. PMID: 34509080
-
The Treatment of Primary Lymphoepithelioma-Like Carcinoma in the Head and Neck and Nasopharyngeal Carcinoma.Cancer Med. 2024 Nov;13(22):e70389. doi: 10.1002/cam4.70389. Cancer Med. 2024. PMID: 39540315 Free PMC article. Review.
-
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.J Clin Oncol. 2021 Mar 1;39(7):840-859. doi: 10.1200/JCO.20.03237. Epub 2021 Jan 6. J Clin Oncol. 2021. PMID: 33405943
Cited by
-
Real-time artificial intelligence-assisted detection and segmentation of nasopharyngeal carcinoma using multimodal endoscopic data: a multi-center, prospective study.EClinicalMedicine. 2025 Feb 15;81:103120. doi: 10.1016/j.eclinm.2025.103120. eCollection 2025 Mar. EClinicalMedicine. 2025. PMID: 40026832 Free PMC article.
-
Schisandrin B targets CDK4/6 to suppress proliferation and enhance radiosensitivity in nasopharyngeal carcinoma by inducing cell cycle arrest.Sci Rep. 2025 Mar 12;15(1):8452. doi: 10.1038/s41598-025-92992-9. Sci Rep. 2025. PMID: 40069371 Free PMC article.
-
A coordinate registration-based structured magnetic resonance imaging reporting method for nasopharyngeal carcinoma: a preliminary study.Quant Imaging Med Surg. 2025 Mar 3;15(3):2444-2456. doi: 10.21037/qims-24-1127. Epub 2025 Feb 26. Quant Imaging Med Surg. 2025. PMID: 40160624 Free PMC article.
-
Individual and community-level social determinant impact on HPV-differentiated nasopharyngeal carcinoma disparities in the USA.Sci Rep. 2025 Jul 23;15(1):26778. doi: 10.1038/s41598-025-10522-z. Sci Rep. 2025. PMID: 40702052 Free PMC article.
-
The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.Head Neck. 2021 Sep;43(9):2755-2763. doi: 10.1002/hed.26739. Epub 2021 May 17. Head Neck. 2021. PMID: 33998094 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials